The global oxaliplatin market is undergoing rapid transformation as oncology care advances toward more targeted and effective chemotherapeutic regimens. Valued at USD 971 million in 2024, the market is projected to expand significantly, reaching USD 1.82 billion by 2032 at a CAGR of 9.6%. Rising